Claritev (CTEV) Bank of America Global Healthcare Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Bank of America Global Healthcare Conference 2026 summary
14 May, 2026Strategic vision and business outlook
Focus on healthcare impact with 3,000 associates and a strong, mission-driven culture set the foundation for 2024 and beyond.
Core business is described as sticky, with Claims Intelligence up 8.4% year-over-year in Q1 and stable out-of-network market.
Network business is a strategic asset, with aggressive expansion into the TPA space and medium-to-long-term growth expected in Payment and Revenue Integrity.
Provider and public sector verticals are being developed, including pilots in the UAE and U.S., and a significant contract for World Trade Center first responders.
Revenue targets set at $1.1B by 2028 and $1.3B by 2030, with EBITDA goals of $675M and $800M, respectively, and expectations for strong free cash flow yields.
Sales performance and pipeline development
Q1 saw record bookings of $44.1M, with a 70/30 split between organic growth and net new clients, and 36 new logos added in the last five to six quarters.
Sales infrastructure has been strengthened with new leadership and vertical alignment, supporting end-to-end client management.
Gross Revenue Retention remains high at 93%-95%, and the pipeline has expanded to support $100M in annual bookings.
Public sector and provider opportunities are both being pursued, with the World Trade Center contract contributing $5M in ACV.
Sales cycle from booking to revenue conversion is typically 6-12 months, depending on deal type.
Technology, innovation, and client relationships
AI is leveraged for product development, with 53% of code generated by AI in Q1, and is seen as an offensive opportunity.
Deep, long-term client relationships, data rights, and workflow integration are key differentiators against AI-driven competition.
NSA product leadership is highlighted, with ongoing automation and a published product roadmap through 2026.
Clients are engaged through transparent communication, regular business reviews, and dedicated sales representatives.
Investments in technology modernization are expected to drive capital efficiency and support future growth.
Latest events from Claritev
- Q1 2026 revenue grew 5.8% to $244.7M, with margin gains but continued net losses.CTEV
Q1 20267 May 2026 - All proposals, including director elections and plan amendments, were approved without contest.CTEV
AGM 202629 Apr 2026 - 2026 guidance targets $980M–$1B revenue, 61–62% EBITDA margin, and AI-driven growth.CTEV
Investor Day 202629 Apr 2026 - Definitive additional proxy materials outline voting procedures for the upcoming meeting.CTEV
Proxy filing20 Mar 2026 - Board recommends all proxy proposals amid strong 2025 results and governance enhancements.CTEV
Proxy filing20 Mar 2026 - Record bookings, robust AI-driven growth, and disciplined investment fuel expansion.CTEV
Status update6 Mar 2026 - Revenue and EBITDA grew, losses narrowed, and 2026 outlook includes buybacks and expansion.CTEV
Q4 202523 Feb 2026 - Q2 2024 net loss was $576.7M on $233.5M revenue, driven by a $553.7M impairment.CTEV
Q2 20242 Feb 2026 - Q3 2024 net loss surged on a $361.6M impairment as revenue fell 5.1% year-over-year.CTEV
Q3 202416 Jan 2026